Improving CAR T-Cell Therapies With Greater Understanding of Cancer Immunology
October 8th 2019Eduardo Sotomayor, MD, discusses the evolution of CAR T-cell therapy, adverse events that require careful monitoring, and novel strategies under development that may mitigate toxicity and improve T-cell persistence.
Dr. Sotomayor on the Durability of CAR T Cells in Hematologic Malignancies
October 4th 2019Eduardo Sotomayor, MD, professor of medicine, Department of Hematology and Oncology, and director, GW Cancer Center, discusses the durability of CAR T cells, as well as ways to combat immune escape mechanisms in hematologic malignancies.